We apply iPSC expertise and commercial manufacturing experience to cell therapy to deliver iPSC solutions to your requirements. Our offerings include comprehensive services for basic research, proof-of-concept studies, process development and large-scale custom manufacturing of a range of cell types.

Assessment of drug efficacy and safety requires predictive models and assays. We provide hiPSC-based solutions for cardiovascular and neural drug screening by combining our demonstrated expertise in iPSC manufacturing and model generation to offer you predictive and translational assays at any throughput.

Ncardia develops and delivers state-of-the-art integrated cardiovascular services to enhance the assessment of cardiac safety and toxicity of drug candidates. Our services are based on fully functional and validated hiPSC-derived cell models that are manufactured in under strict quality assurance.